Article
08 Apr 2022
FDA Issues Draft Guidance On Human Gene Therapy Products Incorporating Human Genome Editing
AUTHORS CONTENT
Article
06 Apr 2022
QMSR: Welcomed By The Industry, But Lacking In Practicality
Article
17 Mar 2022
New Jersey Court Affirms Prohibition Of Physician Practice From Opening And Operating In-Office Pharmacy
Article
14 Mar 2022
FDA's Loud And Clear Message: Engage With FDA Early And Formally
Article
10 Mar 2022
Quality Management System Regulation (QMSR) – Harmonizing The Quality System Regulation (QSR) With ISO 13485:2016
Article
21 Feb 2022
FDA Releases Draft Guidance On Digital Health Technologies For Remote Data Acquisition In Clinical Investigations
Article
17 Feb 2022
Two Years In: An Inside Look At COVID-19 Relief Fraud And What To Expect Next (Video)
Article
16 Feb 2022
FDA Releases Draft Guidance On Use Of Real-World Evidence For Drug & Biological Products
Article
16 Feb 2022
Digital Transformation In The Life Sciences (Video)
Article
16 Feb 2022
HHS Reverses Policy Prohibiting FDA Review Of Lab-Developed Tests (Video)
Article
28 Jan 2022
FDA Oks Mail-Order Mifepristone: State Laws May Inhibit Its Use
Article
29 Dec 2021
De Novo Classification Final Rule To Take Effect Next Year
Article
29 Dec 2021
3 Key Takeaways From FDLI's FDA Center Compliance Directors: Presentations And Q&A Session
Article
29 Dec 2021
Key Takeaways From FDLI's Enforcement, Litigation, And Compliance Conference Keynote Address
Article
24 Dec 2021
What New FDA Policy Means For COVID Tests And Beyond
Article
19 Nov 2021
Morrison & Foerster Partners Speak At FDLI's Digital Health Technology And Regulation Conference
Article
19 May 2021
New Face Mask Performance Standard Has Consumers Covered
Article
14 May 2021
COVID-19 Vaccines: And Then There Were Three (Again)
Article
14 May 2021
CTA Publishes New Standard For Healthcare AI
Article
06 May 2021
Ninth Circuit Weighs In On Fraud-on-the-FDA Theory, Marketing Devices For Off-Label Use, And Kickbacks
